BRAINAURORA-B (06681) has entered into a strategic cooperation agreement with Silk Road Boat to expand into the Malaysian market and further internationalize its layout.

BRAINAURORA-B (06681) announced that the company has entered into a strategic cooperation agreement with Silk Road Boat Technology Co., Ltd. (Silk Road Boat) to carry out in-depth strategic cooperation in areas such as localization, market promotion, and research and transformation of cognitive impairment digital therapy products in Malaysia and Southeast Asia, aiming to promote the development of the digital health industry. As one of the important economies in Southeast Asia, Malaysia is facing challenges of rapid population aging and increasing demand for mental health services. According to data from the Malaysian Statistics Department, the population aged 60 and above in the country is expected to reach 3.8 million by 2023. At the same time, mental health issues among young people are becoming increasingly prominent. Although the Malaysian government has implemented various mental health policies, diagnostic and treatment resources are still scarce, with a ratio of psychological counselors only 1:52,000, far below the international standard of 1:500, creating a significant market gap. As a pioneer in the Chinese cognitive impairment digital therapy market, the company's core product, the "Brain Function Information Management Platform Software System," is the first cognitive impairment digital therapy product in China to receive regulatory approval and has been included in the reimbursement list of provincial medical insurance in 30 provinces in China. Silk Road Boat's parent company, China Silk Road Group Co., Ltd. (Silk Road Group), is a comprehensive multinational group that practices the Belt and Road Initiative and upholds the concept of "consultation, joint construction, and shared benefits," driving industry integration with digital technology. Silk Road Group pioneered technologies such as Digital Trade Infrastructure (DTI) to build business matrices covering "Digital Silk Road" and "Health Silk Road," which have helped over a hundred companies achieve breakthroughs in overseas revenue. Its digital trading platform has an annual transaction volume exceeding 20 billion RMB, and its digital logistics platform has shipped over 170 million items. In the healthcare field, Silk Road Group relies on its self-developed digital healthcare platform D-Health to promote cross-border collaboration in healthcare resources exceeding 5 billion RMB, and has long been involved in international medical assistance and public welfare projects, possessing deep cross-border resource integration and localization capabilities. In Malaysia and other countries in Southeast Asia, Silk Road Group has rich government public resources, medical industry channel networks, and project operation experiences, as well as strong capabilities in local policy interpretation, resource coordination, and project implementation. According to the agreement, the cooperation mainly includes: (I) Establishment of a Special Laboratory: Silk Road Boat will assist the company in setting up a "Cognitive Impairment Digital Therapy Special Laboratory" in Malaysia, coordinating local approvals, site planning, equipment imports, etc.; the company will provide technical solutions and research support, leading research and operations. (II) Application for National Innovation Pilot Concept Verification Project: Silk Road Boat will lead the coordination with relevant departments in Malaysia to assist the company in applying for the national innovation pilot concept verification project; both parties will jointly promote the application and implementation. (III) Landing of Hospital Clinical Pilot Projects: Silk Road Boat will select and connect target hospitals, promote the signing of clinical pilot cooperation agreements; the company will be responsible for product localization adaptation, medical training, and data collection. (IV) Synchronized Market Expansion in Malaysia: Both parties will integrate product, channel, brand, and other resources to jointly carry out market promotion and commercialization. (V) Cooperation in Southeast Asia Market Development: Based on cooperation in Malaysia, gradually expand to other Southeast Asian countries such as Indonesia, Thailand, and Vietnam. The Board believes that this cooperation will bring long-term development opportunities for the company and create sustainable value for shareholders. By deepening its international layout and expanding overseas markets, the company has already promoted business promotion and operations in Hong Kong, Macau, and Singapore, accumulating experience in overseas markets. This cooperation with Silk Road Boat marks the company's official entry into the Malaysian market, further expanding its business network in Southeast Asia, helping to systematically export the digital therapy experience and technology system verified in the Chinese market to regional markets with growth potential and policy support, further expanding the company's brand influence and business coverage internationally. Leveraging local resources to accelerate market entry: Silk Road Boat has rich government and medical resources networks in Malaysia, which can assist the company in efficiently completing product access, channel linkage, and pilot landing, shorten market penetration cycles, and enhance commercialization efficiency. Enhancing brand influence and regional synergy: This cooperation further strengthens the company's brand authority and professional image in the digital healthcare field. With Silk Road Boat's medical industry channel networks in Malaysia and many Southeast Asian countries, the company can accelerate the landing of products in local medical institutions, shorten market penetration cycles, and expand into diverse markets such as digital health management.